Xconomy: Accelerators Mirina Advances, Qliance Nabs Bezos Bucks, Spiration Adds $6.5M Debt, & More Seattle-Area Life Sciences News
Summary
Accelerator’s Mirina Advances, Qliance Nabs Bezos Bucks, Spiration Adds $6.5M Debt, & More Seattle-Area Life Sciences News Xconomy Seattle — There was quiet before the storm this week, as Dendreon is eagerly awaiting the FDA’s decision by May 1 on whether it will clear the company’s prostate cancer drug for sale.—Accelerator’s microRNA startup, Mirina, has made enough progress in its early days that it has secured an undisclosed “expansion” round of financing led by Versant Ventures.The Seattle-based company, which deals directly with patients and doesn’t accept health insurance for primary care medical services, nailed down a $6 million financing from Jeff Bezos, Michael Dell, Drew Carey and others.—Spiration, the Redmond, WA-based maker of devices for lung diseases, has collected another $6.5 million in debt financing from a single investor, according to a regulatory filing.The founder and longtime CEO of Targeted Genetics is taking on a new role for the WBBA as a commercialization advisor to life sciences entrepreneurs on a part-time basis.